Wallaby Medical to Acquire phenox GmbH
Posted on 04/24/2022
On April 21, 2022, Wallaby Medical Holding, Inc. acquired phenox GmbH, a Bochum, Germany-based neurovascular disease treatment company, for approximately €500 million. The acquisition is one of the largest cross-border transactions in the medical device industry globally in recent years and is driven by strong growth opportunities in both product portfolio and geographic coverage. Wallaby funded the acquisition of phenox from the proceeds of its Series D financing round supported by leading healthcare investors.
Wallaby’s product portfolio includes the Avenir Coil System, a technically differentiated neuro embolic coil system for treating intracranial aneurysms and other neurovascular abnormalities, the Esperance Aspiration Catheter, cleared in the U.S. and China for ischemic stroke treatment procedures, and the Esperance Distal Access Catheter, which was approved for delivery assistance in China.